Southern National Banc. of Virginia (SONA) Rating Lowered to Hold at Zacks Investment Research

Southern National Banc. of Virginia (NASDAQ:SONA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “Headquartered in Charlottesville Virginia, Sonabank is a new regional bank founded by an experienced banking team with close to hundred years of banking experience. They offer a full line of products and services for personal and business banking. Sonabank specializes in small to medium sized business banking. They have extensive experience in Small Business Administration loans as well as other types of financing suited for businesses. “

How to Become a New Pot Stock Millionaire

Separately, BidaskClub upgraded Southern National Banc. of Virginia from a “sell” rating to a “hold” rating in a report on Thursday, January 11th.

Shares of Southern National Banc. of Virginia stock opened at $15.76 on Thursday. The company has a debt-to-equity ratio of 0.18, a current ratio of 0.94 and a quick ratio of 0.94. Southern National Banc. of Virginia has a 1-year low of $15.11 and a 1-year high of $18.48. The stock has a market cap of $383.04, a price-to-earnings ratio of 17.91 and a beta of 0.29.

Southern National Banc. of Virginia (NASDAQ:SONA) last issued its quarterly earnings results on Friday, January 26th. The bank reported $0.26 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.24 by $0.02. Southern National Banc. of Virginia had a return on equity of 5.97% and a net margin of 2.72%. The firm had revenue of $25.30 million during the quarter, compared to the consensus estimate of $24.50 million. sell-side analysts forecast that Southern National Banc. of Virginia will post 1.15 earnings per share for the current year.

In other news, SVP William H. Lagos bought 3,500 shares of Southern National Banc. of Virginia stock in a transaction dated Tuesday, January 16th. The stock was bought at an average cost of $9.20 per share, for a total transaction of $32,200.00. Following the purchase, the senior vice president now directly owns 36,657 shares in the company, valued at approximately $337,244.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Georgia S. Derrico bought 32,000 shares of Southern National Banc. of Virginia stock in a transaction dated Monday, February 26th. The stock was purchased at an average price of $6.29 per share, with a total value of $201,280.00. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 42,218 shares of company stock valued at $316,436. 9.60% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Banc Funds Co. LLC grew its stake in shares of Southern National Banc. of Virginia by 3.5% in the 4th quarter. Banc Funds Co. LLC now owns 1,713,529 shares of the bank’s stock valued at $27,468,000 after buying an additional 57,782 shares during the period. BlackRock Inc. grew its stake in shares of Southern National Banc. of Virginia by 4.5% in the 4th quarter. BlackRock Inc. now owns 1,079,798 shares of the bank’s stock valued at $17,309,000 after buying an additional 46,918 shares during the period. Kennedy Capital Management Inc. grew its stake in shares of Southern National Banc. of Virginia by 9.0% in the 4th quarter. Kennedy Capital Management Inc. now owns 444,010 shares of the bank’s stock valued at $7,117,000 after buying an additional 36,729 shares during the period. Renaissance Technologies LLC grew its stake in shares of Southern National Banc. of Virginia by 19.0% in the 4th quarter. Renaissance Technologies LLC now owns 417,142 shares of the bank’s stock valued at $6,687,000 after buying an additional 66,500 shares during the period. Finally, Royce & Associates LP grew its stake in shares of Southern National Banc. of Virginia by 21.3% in the 4th quarter. Royce & Associates LP now owns 381,904 shares of the bank’s stock valued at $6,122,000 after buying an additional 67,000 shares during the period. Institutional investors own 68.06% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Southern National Banc. of Virginia (SONA) Rating Lowered to Hold at Zacks Investment Research” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3337071/southern-national-banc-of-virginia-sona-rating-lowered-to-hold-at-zacks-investment-research.html.

About Southern National Banc. of Virginia

Southern National Bancorp of Virginia, Inc (Southern National) is the bank holding company for Sonabank (Sonabank). The Company’s principal business is the acquisition of deposits from the general public through its branch offices and deposit intermediaries, as well as the use of these deposits to fund its loan and investment portfolios.

Get a free copy of the Zacks research report on Southern National Banc. of Virginia (SONA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Southern National Banc. of Virginia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Southern National Banc. of Virginia and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cantor Fitzgerald Raises Intuitive Surgical  Price Target to $510.00
Cantor Fitzgerald Raises Intuitive Surgical Price Target to $510.00
JPMorgan Chase Boosts UnitedHealth Group  Price Target to $266.00
JPMorgan Chase Boosts UnitedHealth Group Price Target to $266.00
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Mizuho Reaffirms “Buy” Rating for QUALCOMM
Noah  and PJT Partners  Critical Review
Noah and PJT Partners Critical Review
Head-To-Head Analysis: The Meet Group  & Quotient Technology
Head-To-Head Analysis: The Meet Group & Quotient Technology
Mersana Therapeutics  Stock Rating Upgraded by Zacks Investment Research
Mersana Therapeutics Stock Rating Upgraded by Zacks Investment Research


© 2006-2018 Ticker Report. Google+.